On October 12, 2022 EVERSANA reported that it is attending Informa Connect’s Pharma/Biotech GTN Summit, the foremost and longest-standing event for model-sharing on strategic forecasting, estimates, analytics and reporting for pharma and biotech companies. The hybrid summit will take place November 15-17 in Philadelphia, PA and online (Press release, EVERSANA, OCT 12, 2022, View Source [SID1234621938]). Schedule a meeting with our experts today.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

EVERSANA’s Gross-to-Net Services

Revenue accuracy is extremely important, as errors can negatively impact rebates and promotions. In addition, funds being added or subtracted from the wrong areas of business can lead to stunted revenue, cash crunches or excessive borrowing to fulfill obligations.

EVERSANA partners with our clients to evaluate their processes and offer strategic support that overcome these gross-to-net challenges with:

Gross-to-net automation and process improvements
Best price projections
Insights into contracting strategy impacts on Medicaid liability
Optimization of WAC price strategy